Kite TCF05 Cell Therapy Manufacturing Facility
Size: 260,000 sf + 900 parking spaces
Owner: Kite Pharma, a Gilead Company
Architect: Ewing Cole
The Kite TCF05 Cell Therapy Manufacturing Facility will be a cutting edge biomanufacturing facility for the production of T-Cell therapies focused on curing cancer. The 20-acre site, located in Urbana, Maryland, will include a 200,000 sf manufacturing building, a 60,000 sf office building, and 900 parking spaces.
The buildings will be connected to two electrical service lines which will build reliance and redundancy helping to ensure patient supply. The manufacturing building will consist of prefabricated laboratory units, a warehouse area with a loading dock, and a 78,000 sf shell space constructed for future expansion. The two story office building will include office space, a fitness center with locker rooms, a kitchen, and dining area.